This content is from: Direct Tax

Deals of the week - July 23 2012

Type of DealValueAcquirerTargetAdviser to acquirer (tax)Adviser to target (tax)
Acquisition$6.6 billionBC Partners / CPP Investment BoardSuddenlinkTorys / Fried, Frank, Harris, Shriver & JacobsonLatham & Watkins / Wachtell, Lipton, Rosen & Katz
Acquisition$3.6 billionGlaxoSmithKlineHuman Genome Sciences Wachtell, Lipton, Rosen and Katz / Cleary Gottlieb Steen & HamiltonSkadden, Arps, Slate, Meagher & Flom / DLA Piper
Acquisition$1.9 billionGeorgia GulfPPGJones DayWachtell, Lipton, Rosen & Katz
Acquisition$1.9 billionTPG CapitalPar PharmaceuticalRopes & Gray / Cravath Swaine & MooreOrrick, Herrington & Sutcliffe
Acquisition$1.36 billionCogeco Cable Atlantic BroadbandStikeman Elliott / Simpson Thacher & Bartlett / Wiley Rein Kirkland & Ellis
Acquisition$925 millionThermo Fisher Scientific One LambdaWilmer Cutler Pickering Hale and Dorr / Seth HoogasianSheppard, Mullin, Richter & Hampton
Acquisition$550 millionState Street Corporation Goldman Sachs Administration Services Sullivan & Cromwell
Acquisition$275 millionAccorGrupo PosadasLefosse Advogados
Acquisition$208 millionRBC DexiaOcean PropertiesWongPartnershipLee & Lee
AcquisitionUndisclosedNBCUniversalMSNBC Digital NetworkDavis Polk & Wardwell - Avishai Shachar, Neil Barr
Type of DealValueIssuer/BorrowerLead managers/arrangersAdviser to issuer/borrower (tax)Adviser to lead managers (tax)
Medium-term Note Programme$1.59 billionChangi Airport GroupWongPartnershipAllen & Gledhill
Rights Issue$448 millionSPAusNetMacquarie Group / UBSWongPartnership
Medium-term Note Programme$397 millionKeppel Telecommunications & TransportationUnited Overseas BankAllen & GledhillWongPartnership
Initial Public Offering$215 millionYongdaUBS / HSBC / BOCOMDavis Polk & Wardwell - John Paton Paul Hastings

The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms and Conditions and Privacy Policy before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQ.

Instant access to all of our content. Membership Options | 30 Day Trial